Supplemental table 1.docx (19.43 kB)
Download file

Supplementary Material: Treatment and Overall Survival Among Anti-PD-1 Exposed Advanced Melanoma Patients with Evidence of Disease Progression

Download (19.43 kB)
dataset
posted on 06.12.2021, 16:19 authored by Cathy Anne Pinto, Xinyue Liu, Xiaoyun Li, Emilie Scherrer, Mizuho Kalabis
Table S1 Patient characteristics by type of index therapy

Funding

Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.

History